• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Viracta Therapeutics Inc (NQ: VIRX )

    0.3075 -0.0410 (-11.76%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,381,510
    Open 0.3400
    Bid (Size) 0.2930 (10)
    Ask (Size) 0.3100 (10)
    Prev. Close 0.3485
    Today's Range 0.2900 - 0.3499
    52wk Range 0.2900 - 1.515
    Shares Outstanding 38,410,935
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q2 2024
    VIRX stock results show that Viracta Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Why Is Cancer-Focused Penny Stock Viracta Therapeutics Trading Higher On Wednesday?
    Viracta Therapeutics stock gains after Phase 2 NAVAL-1 trial results for relapsed or refractory EBV+ PTCL cohort. The company plans pipeline reprioritization and a reduction in force. 
    Via Benzinga

    Performance

    YTD
    -47.53%
    -47.53%
    1 Month
    -44.09%
    -44.09%
    3 Month
    -61.90%
    -61.90%
    6 Month
    -56.69%
    -56.69%
    1 Year
    -73.49%
    -73.49%

    More News

    Read More
    Why Is Viracta Therapeutics (VIRX) Stock Up 42% Today?
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Viracta Therapeutics: Q3 Earnings Insights
    Via Benzinga
    Why Digital Turbine Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q1 2024
    Via InvestorPlace
    3 Speculative Penny Stocks Offering High-Upside Potential for Under a Buck
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Is Small-Cap Cancer Drug Developer Viracta Therapeutics Stock Trading Lower On Monday?
    Via Benzinga
    Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    VIRX Stock Earnings: Viracta Therapeutics Misses EPS for Q4 2023
    Via InvestorPlace
    Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    CACI International To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.